413 related articles for article (PubMed ID: 32290429)
21. The Leaky Gut and Altered Microbiome in Chronic Kidney Disease.
Lau WL; Vaziri ND
J Ren Nutr; 2017 Nov; 27(6):458-461. PubMed ID: 29056165
[TBL] [Abstract][Full Text] [Related]
22. The intestinal microbiota, a leaky gut, and abnormal immunity in kidney disease.
Anders HJ; Andersen K; Stecher B
Kidney Int; 2013 Jun; 83(6):1010-6. PubMed ID: 23325079
[TBL] [Abstract][Full Text] [Related]
23. Immunosenescence, gut dysbiosis, and chronic kidney disease: Interplay and implications for clinical management.
Lee TH; Chen JJ; Wu CY; Lin TY; Hung SC; Yang HY
Biomed J; 2024 Apr; 47(2):100638. PubMed ID: 37524304
[TBL] [Abstract][Full Text] [Related]
24. Dietary Fibre Intake Is Associated with Serum Levels of Uraemic Toxins in Children with Chronic Kidney Disease.
El Amouri A; Snauwaert E; Foulon A; Vande Moortel C; Van Dyck M; Van Hoeck K; Godefroid N; Glorieux G; Van Biesen W; Vande Walle J; Raes A; Eloot S
Toxins (Basel); 2021 Mar; 13(3):. PubMed ID: 33808581
[TBL] [Abstract][Full Text] [Related]
25. Altered microbiome in chronic kidney disease: systemic effects of gut-derived uremic toxins.
Lau WL; Savoj J; Nakata MB; Vaziri ND
Clin Sci (Lond); 2018 Mar; 132(5):509-522. PubMed ID: 29523750
[TBL] [Abstract][Full Text] [Related]
26. The impact of gut microbiota on kidney function and pathogenesis.
Mahmoodpoor F; Rahbar Saadat Y; Barzegari A; Ardalan M; Zununi Vahed S
Biomed Pharmacother; 2017 Sep; 93():412-419. PubMed ID: 28654798
[TBL] [Abstract][Full Text] [Related]
27. Microbiome modulation to correct uremic toxins and to preserve kidney functions.
Caggiano G; Cosola C; Di Leo V; Gesualdo M; Gesualdo L
Curr Opin Nephrol Hypertens; 2020 Jan; 29(1):49-56. PubMed ID: 31725010
[TBL] [Abstract][Full Text] [Related]
28. Link between gut microbiota dysbiosis and chronic kidney disease.
Noce A; Marchetti M; Marrone G; Di Renzo L; Di Lauro M; Di Daniele F; Albanese M; Di Daniele N; De Lorenzo A
Eur Rev Med Pharmacol Sci; 2022 Mar; 26(6):2057-2074. PubMed ID: 35363356
[TBL] [Abstract][Full Text] [Related]
29. Uremia-Induced Gut Barrier Defect in 5/6 Nephrectomized Mice Is Worsened by
Tungsanga S; Panpetch W; Bhunyakarnjanarat T; Udompornpitak K; Katavetin P; Chancharoenthana W; Chatthanathon P; Somboonna N; Tungsanga K; Tumwasorn S; Leelahavanichkul A
Int J Mol Sci; 2022 Feb; 23(5):. PubMed ID: 35269654
[TBL] [Abstract][Full Text] [Related]
30. Diet, gut microbiome and indoxyl sulphate in chronic kidney disease patients.
Yang CY; Tarng DC
Nephrology (Carlton); 2018 Oct; 23 Suppl 4():16-20. PubMed ID: 30298666
[TBL] [Abstract][Full Text] [Related]
31. Association of Sarcopenia and Gut Microbiota Composition in Older Patients with Advanced Chronic Kidney Disease, Investigation of the Interactions with Uremic Toxins, Inflammation and Oxidative Stress.
Margiotta E; Caldiroli L; Callegari ML; Miragoli F; Zanoni F; Armelloni S; Rizzo V; Messa P; Vettoretti S
Toxins (Basel); 2021 Jul; 13(7):. PubMed ID: 34357944
[TBL] [Abstract][Full Text] [Related]
32. Effects of lactulose on renal function and gut microbiota in adenine-induced chronic kidney disease rats.
Sueyoshi M; Fukunaga M; Mei M; Nakajima A; Tanaka G; Murase T; Narita Y; Hirata S; Kadowaki D
Clin Exp Nephrol; 2019 Jul; 23(7):908-919. PubMed ID: 30895529
[TBL] [Abstract][Full Text] [Related]
33. The clinical impact of gut microbiota in chronic kidney disease.
Kim SM; Song IH
Korean J Intern Med; 2020 Nov; 35(6):1305-1316. PubMed ID: 32872729
[TBL] [Abstract][Full Text] [Related]
34. Evaluation of the impact of gut microbiota on uremic solute accumulation by a CE-TOFMS-based metabolomics approach.
Mishima E; Fukuda S; Mukawa C; Yuri A; Kanemitsu Y; Matsumoto Y; Akiyama Y; Fukuda NN; Tsukamoto H; Asaji K; Shima H; Kikuchi K; Suzuki C; Suzuki T; Tomioka Y; Soga T; Ito S; Abe T
Kidney Int; 2017 Sep; 92(3):634-645. PubMed ID: 28396122
[TBL] [Abstract][Full Text] [Related]
35. Emodin via colonic irrigation modulates gut microbiota and reduces uremic toxins in rats with chronic kidney disease.
Zeng YQ; Dai Z; Lu F; Lu Z; Liu X; Chen C; Qu P; Li D; Hua Z; Qu Y; Zou C
Oncotarget; 2016 Apr; 7(14):17468-78. PubMed ID: 27003359
[TBL] [Abstract][Full Text] [Related]
36. The gut microbiome, kidney disease, and targeted interventions.
Ramezani A; Raj DS
J Am Soc Nephrol; 2014 Apr; 25(4):657-70. PubMed ID: 24231662
[TBL] [Abstract][Full Text] [Related]
37. Uremic Toxin-Producing
Shivani S; Kao CY; Chattopadhyay A; Chen JW; Lai LC; Lin WH; Lu TP; Huang IH; Tsai MH; Teng CH; Wu JJ; Hsieh YH; Wang MC; Chuang EY
Front Cell Infect Microbiol; 2022; 12():726256. PubMed ID: 35558102
[TBL] [Abstract][Full Text] [Related]
38. Intestinal Chelators, Sorbants, and Gut-Derived Uremic Toxins.
Laville SM; Massy ZA; Kamel S; Chillon JM; Choukroun G; Liabeuf S
Toxins (Basel); 2021 Jan; 13(2):. PubMed ID: 33530404
[TBL] [Abstract][Full Text] [Related]
39. Intestinal Microbiota in Type 2 Diabetes and Chronic Kidney Disease.
Sabatino A; Regolisti G; Cosola C; Gesualdo L; Fiaccadori E
Curr Diab Rep; 2017 Mar; 17(3):16. PubMed ID: 28271466
[TBL] [Abstract][Full Text] [Related]
40. Dysbiosis-Related Advanced Glycation Endproducts and Trimethylamine N-Oxide in Chronic Kidney Disease.
Taguchi K; Fukami K; Elias BC; Brooks CR
Toxins (Basel); 2021 May; 13(5):. PubMed ID: 34069405
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]